Marinus Pharmaceuticals (MRNS)
(Delayed Data from NSDQ)
$1.30 USD
-0.02 (-1.52%)
Updated Aug 23, 2024 03:59 PM ET
After-Market: $1.30 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
F Value C Growth D Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/05/2024
Time: -- |
9/2024 | $-0.45 | -0.19% |
Earnings Summary
For their last quarter, Marinus Pharmaceuticals (MRNS) reported earnings of -$0.60 per share, missing the Zacks Consensus Estimate of -$0.59 per share. This reflects a negative earnings surprise of 1.69%. Look out for MRNS's next earnings release expected on November 05, 2024. For the next earning release, we expect the company to report earnings of -$0.45 per share, reflecting a year-over-year increase of 26.23%.
Earnings History
Price & Consensus
Zacks News for MRNS
Marinus Pharmaceuticals (MRNS) Reports Q2 Loss, Misses Revenue Estimates
MRNS: What are Zacks experts saying now?
Zacks Private Portfolio Services